VITY Vitamins reported in the United States: "The main pharmacological effects of curcumin are anti-oxidation, anti-inflammatory, anti-coagulation, lipid-lowering, anti-atherosclerosis, anti-aging to eliminate free radicals and inhibit tumor growth.
In November 2006, an article in the American Journal of Arthritis and Rheumatism pointed out that curcumin can prevent joint swelling and arthritis, and is effective for cardiovascular diseases and cancer.
Professor Ge Zhongliang of the Academy of Military Medical Sciences has been working on the pharmacological study of curcumin on cancer cells for many years. Through long-term drug research and animal experiments, curcumin is a strong antioxidant, and its molecular structure is special. Selective inhibition of protein tyrosine kinase and platelet-derived growth factor receptors, thereby inhibiting cell proliferation and restore apoptosis for anti-tumor purposes. At the same time, the combination of chemical drugs can achieve 1+1>2 effect on tumor cells.
On the basis of long-term research on curcumin, Professor Ge Zhongliang has developed a formula for the treatment of tumor patients with curcumin as the main component through research and screening of a large number of natural plant drugs. Some patients with tumors have improved after the tumor cells stop spreading and the patient's survival is prolonged. After a part of lung cancer patients were taken together with targeted drugs, the recovery of patients was significantly better than that of targeted drugs alone.
At present, curcumin-based drugs for the treatment of tumors have entered the SFDA new drug declaration process, and it is expected to become the first drug in the future to use curcumin for the treatment of tumor diseases.